T cell-derived suppressive activity: Evidence of autocrine noncytolytic control of HIV type 1 transcription and replication

AIDS Research and Human Retroviruses

Volumn 15, Issue 17, 1999, Pages 1553-1561

  Leith, Jonathan G ^a   Copeland, Karen F T ^b   McKay, Paula J ^a   Bienzle, Dorothee ^a   Richards, Carl D ^a   Rosenthal, Kenneth L ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HELPER CELL; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL TRANSFORMATION, VIRAL; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 2, SAIMIRIINE; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; JURKAT CELLS; LYMPHOKINES; MONOCYTES; PERTUSSIS TOXIN; TRANSCRIPTION, GENETIC; U937 CELLS; VIRULENCE FACTORS, BORDETELLA; VIRUS REPLICATION;

EID: 0033589764     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299309847     Document Type: Article

References (55)

1. Fauci AS: Host factors and the pathogenesis of HIV-induced disease. Nature (London) 1986;384:529-534.
2. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, and Doms RW: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85: 1149-1158.
3. + cells is mediated by the chemokine receptor CC-CKR-5. Nature (London) 1996;381:667-673.
4. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, MacKay CR, LaRosa G, Newman W, Gerard N, Gerard C, and Sodroski J: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
5. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA: CC CKR5: A RANTES, MIP-1α, and MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
6. Deng HK, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmom S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, and Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature (London) 1996;381:661-666.
7. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane domain, G-protein coupled receptor. Science 1996;272:872-877.
8. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, and Koup RA: The role of mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240-1243.
9. Zack JA, Arrigo SJ, Weistman SR, Go AS, Hailslip A, and Chen IS: HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 1990;61: 213-222.
10. Ascher MS, Sheppard HW, Krowka JF, and Bremerman HJ: AIDS as immune system activation. Adv Exp Med Biol 1995;374: 203-210.
11. Ghassemi M, Andersen BR, Reddy VM, Gangadharam PR, Spear GT, and Novak RM: HIV and MAC co-infection of monocytoid cells results in reciprocal enhancement of multiplication. J Infect Dis 1995;171:68-73.
12. Wallis RS, Helfand MS, Whalen CC, Johnson JL, Mugerwa RD, Vjecha M, Okwera A, and Ellner JJ: Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis. Tuberc Lung Dis 1996;77:516-523.
13. Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, Grant RM, and Feinberg MB: Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995; 182:1727-1737.
14. Stanley SK, Ostrowski MA, Justement JS, Gantt K, Hedayati S, Mannix M, Roche K, Schwartzenruber DJ, Fox CH, and Fauci AS: Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;334:1264-1265.
15. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 1996;272:1939-1943.
16. Riley JL, Carroll RG, Levine BL, Berstein W, St. Louis DC, Weislow OS, and June CH: Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation. J Immunol 1997;158: 5545-5553.
17. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Chow H, Sodroski J, Newman W, Koup RA, and Mackay C: CCR5 levels and expression pattern correlate with infectability by a macrophage-tropic HIV-1 in vitro. J Exp Med 1997;185: 1681-1691.
18. Oravecz T, Pall M, and Norcross MA: β-Chemokine inhibition of monocytotropic HIV-1 infection. J Immunol 1996;157:1329-1332.
19. + T cells. Science 1997;276:273-279.
20. + T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous chemokines and the viral inductive effects of other endogenous cytokines. Proc Natl Acad Sci USA 1996;93:14076-14081.
21. + lymphocytes can control HIV infection in vivo by suppressing virus replication. Science 1986;234:1563-1566.
22. + T lymphocytes suppresses HIV replication. Immunology 1989;66:628-630.
23. + T cells. Science 1995;270:1811-1815.
24. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, and Koup RA: Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med 1996;2:412-417.
25. Baier M, Werner A, Bannert N, Matzner K, and Kurth R: HIV suppression and interleukin-16. Nature (London) 1995;378:563.
26. Zhow P, Goldstein S, Devadas K, Tewari D, and Notkins AL: Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: Inhibition of mRNA expression. Nature Med 1997;3: 659-664.
27. Idziorek T, Khalife J, Billaut-Mulot O, Hermann E, Aumercier M, Mouton Y, Vapron A, and Bahr GM: Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD). Clin Exp Immunol 1998;112:84-91.
28. Gao M, Tsuchie H, Detorio MA, Hossain MM, Owatari S, Zhang J, Taniguchi K, Nishimoto A, Shirono H, Koga J, Takata N, Matsumoto T, Yoshizaki K, and Kurimura T: Interleukin-16 does not suppress HIV-1 replication in naturally infected peripheral blood mononuclear cells. AIDS 1997;11:538-539.
29. Copeland KFT, McKay PJ, and Rosenthal KL: Suppression of the human immunodeficiency virus long terminal repeat by CD8+ T-cells is dependent on the NFAT-1 element. AIDS Res Hum Retroviruses 1996;12:143-148.
30. Copeland KFT, McKay PJ, and Rosenthal KL: Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T-cells is not lentivirus specific. AIDS Res Hum Retroviruses 1995;11:1321-1326.
31. Copeland KFT, Leith J, McKay PJ, and Rosenthal KL: CD8+ T-cell supernatants of HIV-1-infected individuals have opposite effects on long terminal repeat-mediated transcription in T cells and monocytes. AIDS Res Hum Retroviruses 1997;13:71-77.
32. Leith JG, Copeland KFT, McKay PJ, Richards CD, and Rosenthal KL: CD8+ T-cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1α and MIP-1β. AIDS 1997;11:575-580.
33. Felber BK and Pavlakis GN: A quantitative bioassay for HIV-1 based on transactivation. Science 1988;239:184-187.
34. Schwartz S, Felber BK, Fenyö EM, and Pavlakis GN: Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines. Proc Natl Acad Sci USA 1989;86:7200-7203.
35. Folks TM, Justement J, Kinter A, Dinarello CA, and Fauci AS: Cytokine-induced expression of HIV-1 in a chronically infected promonocytic cell line. Science 1987;238:800-802.
36. Biesinger B, Muller-Fleckenstein I, Simmer B, Lang G, Wittmann S, Platzer E, Desrosiers RC, and Fleckenstein B: Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci USA 1992;89:3116-3119.
37. Berkhout B, Silverman RH, and Jeang K-T: Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 1989;59:273-282.
38. Peterlin M, Luciw PA, Barr JP, and Walker MD: Elevated levels of mRNA can account for the transactivation of human immunodeficiency virus (HIV). Proc Natl Acad Sci USA 1986;83: 9734-9738.
39. Queen C and Baltimore D: Immunoglobulin gene transcription is activated by downstream sequence elements. Cell 1983;33: 741-748.
40. Kinoshita S, Su I, Armano M, Timmerman LA, Kaneshima H, and Nolan GP: The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 1997;6:235-244.
41. Copeland KFT, McKay PJ, Newton JJ, and Rosenthal KL: Enhancement of HIV-1 replication in human macrophages is induced by CD8+ T cell soluble factors. Clin Exp Immunol 1998;14:87-93.
42. Copeland KFT, McKay PJ, Newton J, and Rosenthal KL: CD8+ T cell-mediated enhancement of tumour necrosis factor-alpha (TNFα) production and HIV-1 LTR-driven gene expression in human monocytic cells is pertussis toxin-sensitive. Clin Exp Immunol 1999;116:479-485.
43. Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kerhl JH, and Fauci AS: TNF-α induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 1989;86:2365-2368.
44. Griffin GE, Leung K, Folks T, Kunkel S, and Nabel GJ: Activation of HIV gene expression during monocyte differentiation by induction of NFκB. Nature (London) 1989;339:70-73.
45. Verghese MW, Charles L, Jakoi L, Dillon SB, and Snyderman R: Role of guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants. J Immunol 1987; 138:4374-4380.
46. Sozzani S, Luini W, Molino M, Jilek P, Bottazzi B, Cerletti C, Matsushima K, and Mantovani A: The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. J Immunol 1991;147:2215-2221.
47. Maciaszek JW, Parada NA, Cruikshank WW, Center DM, Kornfeld H, and Viglianti GA: IL-16 represses HIV-1 promoter activity. J Immunol 1997;158:5-8.
48. Mackewicz CE, Levy J, Cruikshank WW, Kornfeld H, and Center DM: Role of IL-16 in HIV replication. Nature (London) 1996; 383:488-489.
49. Rucker J, Samson M, Doranz BJ, Libert F, Berson JF, Yi Y, Smyth RJ, Collman RG, Broder CC, Vassart G, Doms RW, and Parmentier M: Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 1996;87:437-446.
50. Picard L, Simmons G, Power CA, Meyer A, Weiss RA, and Clapham PR: Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J Virol 1997;71:5003-5011.
51. Lui R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, Koup RA, and Landau NA: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell 1996;86:367-377.
52. Barker E, Bossart KN, Fujimura SH, and Levy JA: CD28 costimulation increases CD8+ cell suppression of HIV replication. J Immunol 1997;159:5123-5131.
53. Scala E, Dóffizi G, Rosso R, Turriziani O, Ferrara R, Mazzone AM, Antonelli G, Aiuti F, and Paganelli R: C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J Immunol 1997;158:4485-4492.
54. + T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytial-inducing HIV-1 in vitro. J Virol 1998;72:876-881.
55. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, and Walker BD: Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997;278:1447-1450.